Amphastar Pharmaceuticals
AMPH
AMPH
116 hedge funds and large institutions have $388M invested in Amphastar Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 9 closing their positions.
Holders
116
Holders Change
+7
Holders Change %
+6.42%
% of All Funds
2.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
42
Reduced
36
Closed
9
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
+$43K
Top Buyers
| 1 |
CAM
1
Cortina Asset Management
Milwaukee,
Wisconsin
|
$4.91M |
| 2 |
MSL
2
Mackay Shields LLC
New York
|
$4.29M |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.47M |
| 4 |
4
Morgan Stanley
New York
|
$3.62M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$31.6M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$818K |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$0 |
| 3 |
3
JPMorgan Chase & Co
New York
|
$5.55M |
| 4 |
4
BlackRock
New York
|
$101M |
| 5 |
5
UBS AM
Chicago,
Illinois
|
$6.35M |
